Richter and Hikma receive FDA approval for denosumab biosimilars EnobyTM and XtrenboTM, referencing Prolia® and Xgeva®, respectively
29/09/2025
Business related Regulatory Biotechnology API - DENOSUMAB PARTNER - HIKMA